TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE Drug Patent Profile
✉ Email this page to a colleague
When do Testosterone Enanthate And Estradiol Valerate patents expire, and when can generic versions of Testosterone Enanthate And Estradiol Valerate launch?
Testosterone Enanthate And Estradiol Valerate is a drug marketed by Watson Labs and is included in two NDAs.
The generic ingredient in TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE is estradiol valerate; testosterone enanthate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol valerate; testosterone enanthate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE?
- What are the global sales for TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE?
- What is Average Wholesale Price for TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE?
Summary for TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Patent Applications: | 4 |
DailyMed Link: | TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE at DailyMed |
US Patents and Regulatory Information for TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE | estradiol valerate; testosterone enanthate | INJECTABLE;INJECTION | 085865-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Watson Labs | TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE | estradiol valerate; testosterone enanthate | INJECTABLE;INJECTION | 085860-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |